Celltrion
068270.KS
$125.74
Share price
-2.37%
Change (1 day)
-2.84%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - Total assets
Total assets on the balance sheet as of December 2023 : $15.39 B
According to Celltrion 's latest financial reports the company's total assets are $15.39 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Celltrion - Total assets on balance sheet (from 2007 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $4.67 B | -2.01% |
| 2021-12-31 | $4.76 B | 3.2% |
| 2020-12-31 | $4.62 B | 38.44% |
| 2019-12-31 | $3.33 B | 6.36% |
| 2018-12-31 | $3.13 B | 1.56% |
| 2017-12-31 | $3.08 B | 29.16% |
| 2016-12-31 | $2.39 B | 6.47% |
| 2015-12-31 | $2.24 B | 5.97% |
| 2014-12-31 | $2.12 B | 12.99% |
| 2013-12-31 | $1.87 B | 12.42% |
| 2012-12-31 | $1.66 B | 37.52% |
| 2011-12-31 | $1.21 B | 18.4% |
| 2010-12-31 | $1.02 B | 111.03% |
| 2009-12-31 | $0.48 B | 20.87% |
| 2008-12-31 | $0.40 B | 505.79% |
| 2007-12-31 | $66.34 M |